Cargando…

Sustainable Control of Onchocerciasis: Ocular Pathology in Onchocerciasis Patients Treated Annually with Ivermectin for 23 Years: A Cohort Study

The evolution and persistence of ocular pathology was assessed in a cohort of Onchocerca volvulus infected patients treated annually with ivermectin for 23 years. Patients were resident in rural Central and Kara Region of Togo and ocular examinations included testing of visual acuity, slit lamp exam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banla, Méba, Tchalim, Solim, Karabou, Potochoziou K., Gantin, Richard G., Agba, Aide I., Kére-Banla, Abiba, Helling-Giese, Gertrud, Heuschkel, Christoph, Schulz-Key, Hartwig, Soboslay, Peter T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041847/ https://www.ncbi.nlm.nih.gov/pubmed/24887413 http://dx.doi.org/10.1371/journal.pone.0098411

Ejemplares similares

Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin
por: Komlan, Kossi, et al.
Publicado: (2018)

Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo
por: Johanns, Saskia I., et al.
Publicado: (2022)

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis
por: Golden, Allison, et al.
Publicado: (2016)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin
por: Wilson, Nana O., et al.
Publicado: (2016)

Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
por: Brieger, William R, et al.
Publicado: (2011)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso
por: Nikièma, Achille S., et al.
Publicado: (2021)

Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2018)

Cytokine and chemokine responses to helminth and protozoan parasites and to fungus and mite allergens in neonates, children, adults, and the elderly
por: Lechner, Christian J, et al.
Publicado: (2013)

The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment
por: Noma, Mounkaila, et al.
Publicado: (2014)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Drawing and interpreting data: Children's impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa
por: Amuyunzu-Nyamongo, Mary, et al.
Publicado: (2011)

Onchocerciasis
Publicado: (1911)

Fifteen Years of Annual Mass Treatment of Onchocerciasis with Ivermectin Have Not Interrupted Transmission in the West Region of Cameroon
por: Katabarwa, Moses N., et al.
Publicado: (2013)

The Cost of Annual versus Biannual Community-Directed Treatment of Onchocerciasis with Ivermectin: Ghana as a Case Study
por: Turner, Hugo C., et al.
Publicado: (2013)

Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon
por: Forrer, Armelle, et al.
Publicado: (2021)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs
por: Dissak-Delon, Fanny Nadia, et al.
Publicado: (2017)

2) Onchocerciasis
por: Tada, Isao
Publicado: (2015)

3) Onchocerciasis
por: Tada, Isao
Publicado: (2015)

Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection
por: Vieira, Juan Carlos, et al.
Publicado: (2007)

Primary motives for demand of ivermectin drug in mass distribution programmes to control onchocerciasis
por: Abanobi, Okwuoma, et al.
Publicado: (2011)

Uncertainty Surrounding Projections of the Long-Term Impact of Ivermectin Treatment on Human Onchocerciasis
por: Turner, Hugo C., et al.
Publicado: (2013)

Interruption of Infection Transmission in the Onchocerciasis Focus of Ecuador Leading to the Cessation of Ivermectin Distribution
por: Lovato, Raquel, et al.
Publicado: (2014)

Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment
por: Coffeng, Luc E., et al.
Publicado: (2014)

African Program for Onchocerciasis Control 1995–2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases
por: Krotneva, Stanimira P., et al.
Publicado: (2015)

Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control
por: Tekle, Afework Hailemariam, et al.
Publicado: (2012)

Navigating the way to onchocerciasis elimination: the feasibility and affordability of Onchocerciasis Elimination Mapping
por: Hamill, Louise, et al.
Publicado: (2022)

Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial
por: Batsa Debrah, Linda, et al.
Publicado: (2020)

Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia
por: Yirga, Daniel, et al.
Publicado: (2010)

Impact of Six Years Community Directed Treatment with Ivermectin in the Control of Onchocerciasis, Western Ethiopia
por: Samuel, Abdi, et al.
Publicado: (2016)

Serious Neurological Adverse Events after Ivermectin—Do They Occur beyond the Indication of Onchocerciasis?
por: Chandler, Rebecca E.
Publicado: (2018)

Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial
por: Colebunders, Robert, et al.
Publicado: (2017)

Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria
por: Omitola, Olaitan Olamide, et al.
Publicado: (2021)

Implementation Challenges of Community Directed Treatment with Ivermectin Program for Control of Onchocerciasis in Ulanga, Tanzania
por: Mushi, Vivian
Publicado: (2021)

Information for onchocerciasis control
por: Hopkins, Adrian
Publicado: (2010)

Onchocerciasis: the beginning of the end?
por: Hopkins, Adrian
Publicado: (2019)

Investing in Onchocerciasis Control: Financial Management of the African Programme for Onchocerciasis Control (APOC)
por: Bundy, Donald A. P., et al.
Publicado: (2015)

Corrigendum to: Navigating the way to onchocerciasis elimination: the feasibility and affordability of Onchocerciasis Elimination Mapping
Publicado: (2022)

The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
por: Abd-Elfarag, Gasim, et al.
Publicado: (2018)

Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually
por: Campillo, Jérémy T., et al.
Publicado: (2020)

Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases
por: Twum-Danso, Nana AY
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_9vj1c6qdaa2lofdd6ninsl89cc